Literature DB >> 11435685

High frequency of spontaneous translocations revealed by FISH in cells from patients with the cancer-prone syndromes ataxia telangiectasia and Nijmegen breakage syndrome.

M Stumm1, S Neubauer, S Keindorff, R D Wegner, P Wieacker, R Sauer.   

Abstract

The application of fluorescence in situ hybridization (FISH) using whole-chromosome paints (WCPs) is proving to be a very powerful technique for revealing chromosomal instability that, for the most part, has gone undetected by conventional cytogenetic analysis. We have analyzed the frequency of translocations in lymphocytes and lymphoblastoid cell lines from ataxia telangiectasia (AT) and Nijmegen breakage syndrome (NBS) homozygotes and heterozygotes using a three-color chromosome-painting technique (WCP 1, 2, 4). With this assay we were able to detect an increased frequency of spontaneous translocations in AT homozygotes (median, 18.47 +/- 10.82 translocations per 1,000 metaphase cells; 10 patients) and AT heterozygotes (median, 7.87 +/- 3.15 translocations per 1,000 cells; 7 patients), in comparison to controls (median, 2.26 +/- 1.75 translocations per 1,000 cells; 10 controls). Analysis of NBS homozygotes (median, 19.05 +/- 11.27 translocations per 1,000 cells; 5 patients) and NBS heterozygotes (median, 6.93 +/- 3.04 translocations per 1,000 cells; 6 patients) also showed an increased frequency of translocations in these patients compared to controls. The presence of such hitherto undetected chromosomal aberrations corroborate previous findings of spontaneous chromosomal instability in AT and NBS patients, as manifested by an increased rate of open breaks and rearrangements involving chromosomes 7 and 14. Moreover, we show that the degree of genomic instability in AT and NBS patients is even higher than previously established and that some AT and NBS heterozygotes evidence spontaneous chromosomal instability as well. These increased levels of nonspecific translocations could be an important risk factor for the development of malignancies in homozygotes and heterozygotes for ATM or NBS1 gene mutations. Copyright 2001 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2001        PMID: 11435685     DOI: 10.1159/000056900

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  16 in total

1.  ATM promotes apoptosis and suppresses tumorigenesis in response to Myc.

Authors:  Raju V Pusapati; Robert J Rounbehler; SungKi Hong; John T Powers; Mingshan Yan; Kaoru Kiguchi; Mark J McArthur; Paul K Wong; David G Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

2.  Targeted disruption of NBS1 reveals its roles in mouse development and DNA repair.

Authors:  Jian Kang; Roderick T Bronson; Yang Xu
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

3.  NBS1 rs1805794G>C polymorphism is associated with decreased risk of acute myeloid leukemia in a Chinese population.

Authors:  Na Li; Yanzhe Xu; Jian Zheng; Lan Jiang; Yonghe You; Hongchun Wu; Wei Li; Depei Wu; Yifeng Zhou
Journal:  Mol Biol Rep       Date:  2013-01-03       Impact factor: 2.316

4.  Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder.

Authors:  Regina Waltes; Reinhard Kalb; Magtouf Gatei; Amanda W Kijas; Markus Stumm; Alexandra Sobeck; Britta Wieland; Raymonda Varon; Yaniv Lerenthal; Martin F Lavin; Detlev Schindler; Thilo Dörk
Journal:  Am J Hum Genet       Date:  2009-04-30       Impact factor: 11.025

5.  Effects of antioxidants on cancer prevention and neuromotor performance in Atm deficient mice.

Authors:  Ramune Reliene; Sheila M Fleming; Marie-Françoise Chesselet; Robert H Schiestl
Journal:  Food Chem Toxicol       Date:  2007-08-29       Impact factor: 6.023

6.  Regional distribution of heterozygous 657del5 mutation carriers of the NBS1 gene in Wielkopolska province (Poland).

Authors:  Iwona Ziółkowska; Maria Mosor; Jerzy Nowak
Journal:  J Appl Genet       Date:  2006       Impact factor: 2.653

7.  Experimental antioxidant therapy in ataxia telangiectasia.

Authors:  Ramune Reliene; Robert H Schiestl
Journal:  Clin Med Oncol       Date:  2008-05-20

Review 8.  Nijmegen breakage syndrome (NBS).

Authors:  Krystyna H Chrzanowska; Hanna Gregorek; Bożenna Dembowska-Bagińska; Maria A Kalina; Martin Digweed
Journal:  Orphanet J Rare Dis       Date:  2012-02-28       Impact factor: 4.123

9.  NBS1 Heterozygosity and Cancer Risk.

Authors:  Alessandra di Masi; Antonio Antoccia
Journal:  Curr Genomics       Date:  2008-06       Impact factor: 2.236

10.  Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer.

Authors:  Sylvie Desjardins; Joly Charles Beauparlant; Yvan Labrie; Geneviève Ouellette; Francine Durocher
Journal:  BMC Cancer       Date:  2009-06-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.